Advancing the Cardiovascular Care of the Oncology Patient
Registration Coming Soon!
To receive a notification when registration opens, please click here.
Save the Date!
Advancing the Cardiovascular Care of the Oncology Patient provides clinicians and researchers with the tools needed to improve patient care in your everyday practice. Save the date for this educational experience designed for you to stay on the leading edge of this rapidly evolving field!
Statement of Need
Cancer remains the second leading cause of death in the United States, exceeded only by heart disease, with an estimated 1.8 million new cases in 2020. Cancer treatment can have a diverse array of long-term and late effects, including cardiovascular events such as heart failure, valvular damage, coronary artery disease, and cardiac dysfunction. In this contemporary treatment era, cardiologists, oncologists, and the entire interprofessional team need to understand the different types of cancer therapies (e.g., cytotoxic chemotherapy, radiation therapy, transplantation, targeted and immune therapies) to help mitigate the associated cardiovascular complications.
The goal of this course is to improve awareness, identification, monitoring, and management of cardiovascular disease and conditions, and minimize cardiotoxicity from anticancer therapies to improve overall survival and quality of life of the oncology patient.
This educational activity is intended to address the educational needs of cardiologists, oncologists, internists, pharmacists, nurses, and all members of the interprofessional care team who provide healthcare to the growing population of cancer patients and survivors with cardiovascular concerns.
Ana Barac, MD, PhD, FACC
Medstar Heart and Vascular Institute
Bonnie Ky, MD, MSCE, FACC
University of Pennsylvania School of Medicine
Course Vice Chair
Richard Cheng, MD, FACC
University of Washington
Faculty are subject to change without notice.
Disclosure/Conflict of Interest Statement
As a provider jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), the American College of Cardiology Foundation (ACCF) must ensure balance, independence, objectivity and scientific rigor in all of their directly provided or jointly provided/co-provided educational activities. Planners, presenters, and other contributors, in a position to control the content are required to disclose to the audience all relevant financial relationships he/she and/or his/her spouse or domestic partner may have, occurring within the past 24 months, with any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. When an unlabeled use of a commercial product or an investigational use not yet approved for any purpose is discussed during an educational activity, the contributor should disclose that the product is not labeled for the use under discussion or that the product is still investigational.
ACCF is committed to providing its learners with high-quality activities and materials that promote improvements and quality in health care and not a specific proprietary business or commercial interest. The intent of this disclosure is not to prevent participation in educational activities by persons with a financial or other relationship, but rather to provide learners with information on which they can make their own determination whether financial interests or relationships may influence the education activity.
ACCF assesses conflicts of interest (COI) with its faculty, planners, managers, staff and other individuals who are in a position to control the content of certified activities. All relevant potential conflicts of interest that are identified are thoroughly vetted by course directors, ACCF education staff, and members of the Accreditation Compliance Workgroup (ACWG) through a process that includes appropriate peer review for fair balance, scientific objectivity and validity, and patient care and safety recommendations.
ACCF has taken the necessary steps to ensure that all relevant financial relationships have been mitigated.
Please note ACCF staff and the ACWG members involved with this activity have nothing to disclose.
Clinical Topics: Cardio-Oncology